BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38468631)

  • 1. Safety of inhaled nitric oxide withdrawal in severe chronic pulmonary hypertension.
    Pérez-Peñate GM; Juliá-Serdá G; Galván-Fernández H; Alemán-Segura D; León-Marrero F; Garcia-Quintana A; de Larrinoa IR; Ortega-Trujillo JR; Gómez-Sánchez MÁ
    Pulm Circ; 2024 Jan; 14(1):e12344. PubMed ID: 38468631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension.
    Barst RJ; Channick R; Ivy D; Goldstein B
    Pulm Circ; 2012; 2(2):139-47. PubMed ID: 22837854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term inhaled nitric oxide plus dipyridamole for pulmonary arterial hypertension.
    Pérez-Peñate G; Cabrera Navarro P; Ponce González M; Górriz Gómez E; Pulido Duque J; García Quintana A; Juliá Serdá G
    Respiration; 2005; 72(4):419-22. PubMed ID: 16088287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide for respiratory failure in infants born at or near term.
    Barrington KJ; Finer N; Pennaforte T; Altit G
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD000399. PubMed ID: 28056166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
    Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
    Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Inhaled Nitric Oxide Response Predict Tolerance to Therapies and Survival in Patients With Combined Precapillary and Postcapillary Pulmonary Hypertension?
    Krishtopaytis E; Ampnti SA; Obeidat M; Ramahi N; Lane J; Toth D; Paul D; Tonelli AR
    Am J Cardiol; 2023 Nov; 207():363-369. PubMed ID: 37778225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous prostacyclin mitigates inhaled nitric oxide rebound effect: A case control study.
    Hermon M; Golej J; Burda G; Marx M; Trittenwein G; Pollak A
    Artif Organs; 1999 Nov; 23(11):975-8. PubMed ID: 10564300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term inhaled nitric oxide plus phosphodiesterase 5 inhibitors for severe pulmonary hypertension.
    Pérez-Peñate GM; Juliá-Serdà G; Ojeda-Betancort N; García-Quintana A; Pulido-Duque J; Rodríguez-Pérez A; Cabrera-Navarro P; Gómez-Sánchez MA
    J Heart Lung Transplant; 2008 Dec; 27(12):1326-32. PubMed ID: 19059113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-Term Effects of Inhaled Nitric Oxide on Right Ventricular Flow Hemodynamics by 4-Dimensional-Flow Magnetic Resonance Imaging in Children With Pulmonary Arterial Hypertension.
    Schäfer M; Frank BS; Ivy DD; Abman SH; Stenmark KR; Mitchell MB; Browne LP; Barker AJ; Hunter KS; Kheyfets V; Miller-Reed K; Ing R; Morgan GJ; Truong U
    J Am Heart Assoc; 2021 Apr; 10(8):e020548. PubMed ID: 33821682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echocardiographic Assessment of Pulmonary Arterial Hypertension Following Inhaled Nitric Oxide in Infants with Severe Bronchopulmonary Dysplasia.
    Fraga MV; Dysart KC; Stoller JZ; Huber M; Fedec A; Mercer-Rosa L; Kirpalani H
    Neonatology; 2023; 120(5):633-641. PubMed ID: 37573771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled nitric oxide increases endothelin-1 levels: a potential cause of rebound pulmonary hypertension.
    Pearl JM; Nelson DP; Raake JL; Manning PB; Schwartz SM; Koons L; Shanley TP; Wong HR; Duffy JY
    Crit Care Med; 2002 Jan; 30(1):89-93. PubMed ID: 11902294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of inhaled nitric oxide (iNO) in pulmonary hypertension secondary to arteriovenous malformations: a retrospective cohort study from the European iNO registry.
    Chakkarapani AA; Gupta S; Jamil A; Yadav SK; Subhedar N; Hummler HD
    Eur J Pediatr; 2022 Nov; 181(11):3915-3922. PubMed ID: 36066659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide in conjunction with milrinone better stabilized pulmonary hemodynamics after Fontan procedure.
    Cai J; Su Z; Shi Z; Zhou Y; Xu Z; Liu J; Chen L; Xu Z; Yu X; Ding W; Yang Y
    Artif Organs; 2008 Nov; 32(11):864-9. PubMed ID: 18959679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide for respiratory failure in infants born at or near term.
    Finer NN; Barrington KJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD000399. PubMed ID: 17054129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel use of riociguat in infants with severe pulmonary arterial hypertension unable to wean from inhaled nitric oxide.
    Domingo LT; Ivy DD; Abman SH; Grenolds AM; MacLean JT; Breaux JA; Minford KJ; Frank BS
    Front Pediatr; 2022; 10():1014922. PubMed ID: 36533232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of vasodilator test with inhaled nitric oxide for predicting long-term response to oral vasodilators in pulmonary hypertension.
    Morales-Blanhir J; Santos S; de Jover L; Sala E; Paré C; Roca J; Rodriguez-Roisin R; Barberà JA
    Respir Med; 2004 Mar; 98(3):225-34. PubMed ID: 15002758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, controlled trial of low-dose inhaled nitric oxide in the treatment of term and near-term infants with respiratory failure and pulmonary hypertension.
    Cornfield DN; Maynard RC; deRegnier RA; Guiang SF; Barbato JE; Milla CE
    Pediatrics; 1999 Nov; 104(5 Pt 1):1089-94. PubMed ID: 10545552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery.
    Schmid ER; Bürki C; Engel MH; Schmidlin D; Tornic M; Seifert B
    Anesth Analg; 1999 Nov; 89(5):1108-15. PubMed ID: 10553820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects and potential clinical implications of inhaled nitric oxide during right heart catheterization in heart transplant candidates.
    Strong C; Raposo L; Castro M; Madeira S; Tralhão A; Ventosa A; Rebocho MJ; Almeida M; Aguiar C; Neves JP; Mendes M
    ESC Heart Fail; 2020 Apr; 7(2):673-681. PubMed ID: 32045139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of acute hemodynamic effects of inhaled nitric oxide and inhaled epoprostenol in patients with pulmonary hypertension.
    Preston IR; Sagliani KD; Roberts KE; Shah AM; Desouza SA; Howard W; Brennan J; Hill NS
    Pulm Circ; 2013 Jan; 3(1):68-73. PubMed ID: 23662176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.